Validity and reliability of EQ-5D-3L for breast cancer patients in Korea

Health and Quality of Life Outcomes

Volumn 13, Issue 1, 2015, Pages

  Kim, Seon Ha ^a   Jo, Min Woo ^b   Lee, Jong Won ^b,c   Lee, Hyeon Jeong ^b   Kim, Jong Kyung ^a  

^a Dankook University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

Breast cancer; EQ 5D 3L; FACT B; Health related quality of life; Korea

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ANXIETY; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ASSESSMENT TOOL; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEPRESSION; DISEASE DURATION; EDUCATION; EMOTIONAL WELL BEING; EQ-5D-3L; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT INVENTORY; FUNCTIONAL ASSESSMENT OF CANCER THERAPY BREAST CANCER; FUNCTIONAL WELL BEING; HUMAN; KOREA; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PHYSICAL WELL BEING; POSTOPERATIVE PERIOD; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SCORING SYSTEM; SELF CARE; SINGLE WOMAN; SOCIAL WELL BEING; TEST RETEST RELIABILITY; WELLBEING; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; DEVICES; MIDDLE AGED; PSYCHOLOGY; PSYCHOMETRY; QUESTIONNAIRE; REPRODUCIBILITY; SOUTH KOREA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; SURVEYS AND QUESTIONNAIRES;

EID: 84951840921     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-015-0399-x     Document Type: Article

References (28)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. The Korea Central Cancer Registry, National Cancer Center, Ministry of Health and Welfare. Annual report of cancer statistics in Korea in 2011. Seoul: Ministry of Health and Welfare; 2013.
3. Nayfield SG, Ganz PA, Moinpour CM, Cella DF, Hailey BJ. Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res. 1992;1:203-10.
4. Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care. 1996;34:702-22.
5. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40:113-28.
6. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53-72.
7. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271-92.
8. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programme. New York: Oxford University Press; 2005.
9. Lee CF, Luo N, Ng R, Wong NS, Yap YS, Lo SK, et al. Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-dimension (EQ-5D-5 L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT-B), in Asian breast cancer patients. Qual Life Res. 2013;22:1745-51.
10. Brooks R, Rabin R, de Charro F. The Measurement and Valuation of Health Status Using Eq-5D: A European Perspective: Evidence from the Euroqol Biomed Research Programme. Dordrecht, The Netherlands. London: Kluwer Academic Publishers; 2003.
11. Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health. 2009;12:1187-93.
12. Kim MH, Cho YS, Uhm WS, Kim S, Bae SC. Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res. 2005;14:1401-6.
13. Kim SH, Hwang JS, Kim TW, Hong YS, Jo MW. Validity and reliability of the EQ-5D for cancer patients in Korea. Support Care Cancer. 2012;20:3155-60.
14. Kim SH, Kim HJ, Lee SI, Jo MW. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5 L in cancer patients in Korea. Qual Life Res. 2012;21:1065-73.
15. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol. 1997;15:974-86.
16. Park BW, Lee S, Lee AR, Lee KH, Hwang SY. Quality of Life Differences between Younger and Older Breast Cancer Patients. J Breast Cancer. 2011;14:112-8.
17. Yoo HJ, Ahn SH, Eremenco S, Kim H, Kim WK, Kim SB, et al. Korean translation and validation of the functional assessment of cancer therapy-breast (FACT-B) scale version 4. Qual Life Res. 2005;14:1627-32.
18. Lu W, Cui Y, Zheng Y, Gu K, Cai H, Li Q, et al. Impact of newly diagnosed breast cancer on quality of life among Chinese women. Breast Cancer Res Treat. 2007;102:201-10.
19. Lu W, Cui Y, Chen X, Zheng Y, Gu K, Cai H, et al. Changes in quality of life among breast cancer patients three years post-diagnosis. Breast Cancer Res Treat. 2009;114:357-69.
20. Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, et al. Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt). 2007;16(9):1348-61.
21. Nissen MJ, Swenson KK, Ritz LJ, Farrell JB, Sladek ML, Lally RM. Quality of life after breast carcinoma surgery: a comparison of three surgical procedures. Cancer. 2001;1(91):1238-46.
22. Chae YR, Seo K. Health-related quality of life in women with breast cancer in Korea: do sociodemographic characteristics and time since diagnosis make a difference? Oncol Nurs Forum. 2010;37:E295-303.
23. Park JH, Jun EY, Kang MY, Joung YS, Kim GS. Symptom experience and quality of life in breast cancer survivors. J Korean Acad Nurs. 2009;39:613-21.
24. Ahn SH, Park BW, Noh DY, Nam SJ, Lee ES, Lee MK, et al. Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol. 2007;18:173-82.
25. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74.
26. Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res. 2005;19:231-40.
27. Lee CF, Ng R, Luo N, Wong NS, Yap YS, Lo SK, et al. The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients. Support Care Cancer. 2013;21:201-9.
28. Lang HC, Chuang L, Shun SC, Hsieh CL, Lan CF. Validation of EQ-5D in patients with cervical cancer in Taiwan. Support Care Cancer. 2010;18:1279-86.